NFG
FLNA

Next Financial Group’s Filana Therapeutics FLNA Stock Holding History

Next Financial Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-71
Closed – – 1927
2015
Q3 		$0 Hold
71
– – ﹤0.01% 1941
2015
Q2 		$0 Hold
71
– – ﹤0.01% 1942
2015
Q1 		$0 Sell
71
-29
-29% -$391 ﹤0.01% 1948
2014
Q4 		$1K Sell
100
-71
-42% -$1.23K ﹤0.01% 1833
2014
Q3 		$5K Buy
+171
New +$5.2K ﹤0.01% 2064

Other funds holding FLNA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Next Financial Group's FLNA Position: Q4 2015 in Review

Next Financial Group sold out of Filana Therapeutics (FLNA) in Q4 2015, closing a stake of 71 shares.

Next Financial Group first reported a position in FLNA in Q3 2014 and held it in 5 quarters. The position peaked at $5K in Q3 2014. 49 funds tracked by Wall St. Rank hold FLNA as of Q4 2015.

  • Next Financial Group reported no remaining Filana Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Next Financial Group sold 71 Filana Therapeutics shares in Q4 2015.
  • Next Financial Group first reported a position in Filana Therapeutics in Q3 2014 and held it in 5 quarters.
  • Next Financial Group's Filana Therapeutics position peaked at $5K in Q3 2014.
  • 49 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2015.

Based on Next Financial Group's 13F filing for Q4 2015, filed 2 Feb 2016.